Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives of this study are to evaluate the efficacy and safety of 2 SC dosing tiers of ustekinumab in the treatment of dolescent subjects 12 to 18 years of age with moderate to severe chronic plaque psoriasis.
Critère d'inclusion
- Moderate to severe plaque-type psoriasis